Skip to main content
Funded Studies

Ramakrishna Venugopalan, PhD

Senior Principal Engineer, R&D at Codman & Shurtleff, Inc.

Location: Raynham, MA United States

Ramakrishna Venugopalan earned a BE in Electronics and Instrumentation Engineering (1992) from Annamalai University in India, and a PhD (1998) in Biomedical Engineering from the University of Alabama at Birmingham (UAB). From 1998 to 2002 he was a tenure-track faculty member at the UAB, where he established and directed an industry-academia-government funded translational research program on minimally invasive devices (over a dozen implanted products in current clinical use, and nine MS and three PhD students graduated). He also consulted for over 20 companies; the engagements spanning technology/product/ process development to regulatory filing support.

He was recruited by Codman (the neurosurgical division for J&J) in 2002, and is currently their Senior Principal Engineer.At Codman he has lead R&D programs on passive/active implants and drug-device combinations. His general management expertise encompasses: managing an R&D team through reorganization, creating a resource management/prioritization process for concurrent product development efforts, providing decisive guidance on organic and inorganic opportunities and execution of a gap analysis on an underperforming multinational joint-venture.

Dr. Venugopalan has co-authored over 20 journal articles, three book chapters, three patents/disclosures and three international standards. He has reviewed NIH-SBIR grant proposals, is a Journal of Applied Biomaterials Editorial Board member, and chaired an ASM Biomaterials conference. He has received the Linn-Henley Outstanding Student Achievement Award and the Outstanding Engineering Faculty Award from UAB, and Global Standards of Leadership Award from Codman, J&J. He is currently a company-sponsored candidate in the Sloan Fellows Program in Innovation and Global Leadership at MIT.


Associated Grants

  • Utilizing Novel Tracers to Determine the Distribution of Therapeutic Agents In Vivo

    2008


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.